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Summary We report on the establishment of a model for differentiation induction in sarcomas, using the
clonal rhabdomyosarcoma cell line BA-HAN-IC. This rhabdomyosarcoma cell line is composed of
morphologically undifferentiated mononuclear stem cells, some of which spontaneously fuse to form
terminally differentiated multinuclear myotube-like giant cells. The deprivation of fetal calf serum (FCS) or
the exposure to retinoic acid, respectively, resulted in a significant inhibition of proliferation (P<0.001) and a
marked increase in cellular differentiation as shown by a significant increase in the number of myotube-like
giant cells (P<0.001) and in the creatine kinase activity (P<0.05) used as a biochemical marker of
differentiation. Furthermore, after exposure to retinoic acid about 30% of the mononuclear tumour cells
exhibited morphological features of rhabdomyogenic differentiation, such as bundles of thick and thin
myofilaments, which had never been observed in the mononuclear cells of untreated cultures. These results
confirm that the inverse linkage between proliferation and differentiation known from embryonic myogenesis
is preserved in our rhabdomyosarcoma cell line. The failure to induce terminal differentiation by exposure to
retinoic acid in all the cells of our clonal cell line indicates that some tumour cells might epigenetically be
blocked from responding to retinoic acid. The temporary growth retardation observed after FCS-deprivation
suggests that autocrine stimulation of proliferation may be operating in our cell line, too.
Cancer cells have not necessarily lost all the genes that
control proliferation and differentiation. Thus, in many
cancers at least some of the tumour cells exhibit abortive
attempts at normal differentiation, sometimes proceeding to
terminally differentiated post-mitotic cells, as was shown for
myeloid leukaemias, squamous cell carcinomas, teratocarci-
nomas, neuroblastomas and rhabdomyosarcomas (Pierce,
1974a,b; Dexter et al., 1977; Strickland & Mahdavi, 1978;
Linder et al., 1981; Moore et al., 1986; Paukovits et al.,
1986; Sidell et al., 1986; Sachs, 1987; Gabbert et al., 1988).
These observations stimulated attempts to induce differentia-
tion as an alternative to standard cytotoxic chemotherapy
(for review see Freshney, 1985).
Sarcomas have received less attention, partly because cell
type specific markers of differentiation are not easily avail-
able in many established sarcoma cell lines. We now report
the establishment of a new model for differentiation induc-
tion in sarcomas, using the clonal rhabdomyosarcoma cell
line BA-HAN-IC, which was derived from a dimethyl-
benzanthracene-induced rhabdomyosarcoma in rat (Gerharz
et al., 1988). This clonal rhabdomyosarcoma cell line BA-
HAN-IC closely imitates embryonic rhabdomyogenesis and
is composed of myogenically committed but morphologically
undifferentiated mononuclear stem cells, some of which fuse
to form multinuclear myotube-like giant cells with morpho-
logical features of rhabdomyogenic differentiation, such as
bundles of thick and thin myofilaments. Furthermore, the
mitotic activity in our rhabdomyosarcoma cell line is entirely
confined to the mononuclear cell compartment, whereas the
myotube-like giant cells have irreversibly withdrawn from
the mitotic cycle and represent terminally differentiated post-
mitotic cells (Gabbert et al., 1988). In this report, we show
that fetal calf serum and retinoic acid are able to affect the
proliferation and differentiation of our clonal rhabdomyo-
sarcoma cell line BA-HAN-IC, and that the control mecha-
nisms of proliferation and differentiation known from




The clonal cell line BA-HAN-Cl was derived from a
dimethylbenzanthracene-induced rhabdomyosarcoma in rat
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(Gerharz et al., 1988). The clonal origin of this cell line had
been confirmed by repeated cloning procedures and investi-
gations were performed with cultures between passage
numbers 10 and 30. The standard growth medium was
Dulbeccos's modified Eagle medium (DMEM, Gibco
Europe, FRG), supplemented with 10% heat-inactivated
fetal calf serum, penicillin and streptomycin. The same
batch of FCS was used for all experiments. Unless otherwise
noted, cultures were refed after four days. The tumour cells
were cultured in Nunclong-flasks (Gibco Europe, FRG) and
incubated in an atmosphere with 5% CO2 at 37°C.
Induction ofdifferentiation
FCS depletion Twenty-four hours after plating of BA-
HAN-IC tumour cells, the standard growth medium with
10% FCS was-substituted by growth medium with a reduced
FCS-concentration (1% and 5%).
Retinoic acid treatment A stock solution of 5mM retinoic
acid (Serva, FRG) was prepared in 95% ethanol. Prelim-
inary experiments showed that concentrations of retinoic
acid exceeding 5pM heavily depressed tumour cell prolife-
ration and resulted in a detachment of the adherent tumour
cells as well as a reduced viability, evidenced by the trypan
blue exclusion test. For differentiation induction, the stock
solution was diluted in standard growth medium to a
concentration of 0.1 ,uM and 1 yM. Prior to the experiments,
the purity of the commercial standard and the calculated
concentrations of retinoic acid were checked using HPLC
(Annesley et al., 1984; Biesalski & Hafner, 1988). The
HPLC-analysis demonstrated a ratio 13-cis:all-trans retinoic
acid of 1:3. Further derivates were not detected. The total
vitamin A concentration in the normal standard medium
supplemented with 10% FCS was 0.3nm. Twenty-four hours
after plating of BA-HAN-IC cells, the standard growth
medium was substituted by growth medium supplemented
with retinoic acid. For light protection, the culture flasks
were wrapped in aluminium foil.
Solvent controls (0.02% ethanol) produced no effects on
BA-HAN-IC tumour cell growth or differentiation.
Assessment of differentiation in vitro
In vitro morphology For scanning electron microscopy and
transmission electron microscopy the tumour cells were
seeded on glass coverslips. After incubation for one week,
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the tumour cells were fixed in situ and further handled as
described previously (Gerharz et al., 1988).
Fusion assay Some 3 x 105 BA-HAN-IC tumour cells each
were seeded into 25cm2 culture flasks. On the bottom of
these culture flasks four arbitrarily located fields had been
marked. The area marked out by these four fields was 1/32
the growth area of the culture flask. After 24 hours the
standard growth medium was completely substituted by the
differentiation-inducing media. The number of myotube-like
giant cells in the marked fields was counted by phase
contrast microscopy after 24 and 96 hours. Cells that
contained three or more nuclei were classified as myotubes.
The effects of FCS-depletion (1% and 5%) or retinoic acid
(0.1IgM and I Mm) were evaluated in five replicate culture
flasks per concentration. As a control, the frequency of
myotube-like giant cells was determined in five culture flasks
each with standard growth medium or standard growth
medium with 0.02% ethanol, respectively. At the end of the
observation period of 96 hours, the total number of tumour
cells was determined in each culture flask. Because the
formation of myotube-like giant cells by fusion is affected by
cell density, the effects of different culture conditions on cell
proliferation and cell density had to be compensated. To this
end, the relative frequency of myotube-like giant cells, i.e.
the ratio between the number of myotube-like giant cells and
the total number of cells per culture flask, was calculated.
Creatine kinase activity Triplicate samples of 5 x 106 cells
grown for ten days in growth medium with 1% FCS or
growth medium with 1 M retinoic acid, respectively, were
disrupted by sonication. After centrifugation, the total crea-
tine kinase activity, which was used as a biochemical differ-
entiation marker (Delaporte et al., 1986; Garvin et al., 1986),
was determined at 37°C on an Olympus AU 5031 analyser
using the CK-test (NAC-activated) from Merck (Darmstadt,
FRG).
Assessment ofgrowth properties in vitro
Growth rate Fifteen replicate 25cm2 culture flasks were
each exposed to differentiation-inducing medium. As a
control, 15 replicate 25cm2 flasks were each exposed to
standard growth medium and standard growth medium
supplemented with 0.02% ethanol, respectively. Each culture
flask was seeded with 5 x 104 cells. In each experiment, cells
from three culture flasks were harvested separately each day
for five days and haemocytometer cell counts with the
Neubauer chamber were performed. Cells were not refed
during this period.
Plating efficiency Tumour cells were seeded onto triplicate
96-microwell plates (Gibco Europe, FRG) at definite con-
centrations in differentiation-inducing media and incubated
for 2 weeks without refeeding. The cells had been pretreated
for one week by exposure to either FCS-depleted growth
medium (1% FCS) or growth medium supplemented with
1gM retinoic acid. After 14 days, the plating efficiency was
determined by counting the total number of colonies and
relating them to the control.
Results
Effects of FCS on cellular differentiation
In vitro morphology No phenotypic difference was evident
in FCS-depleted cultures by phase contrast microscopy and
scanning electron microscopy (Figure lc and d) when com-
pared to controls (Figure la and b) in standard growth
medium. The ultrastructural characteristics of both the
mononuclear cells and the myotube-like cells closely corres-
ponded to their counterparts in standard growth medium.
Fusion assay FCS-deprivation resulted in a marked dose-
dependent increase in the absolute number of myotube-like
giant cells after 96 hours in culture. The relative frequency of
myotube-like giant cells, i.e. the ratio between the number of
myotube-like giant cells and the total number of cells per
culture flask, exhibited a statistically significant (P<0.001)
dose-dependent increase. (See Table I.)
Total creatine kinase activity Exposure of BA-HAN-IC
tumour cells to growth medium supplemented with 1% FCS
for 10 days resulted in a statistically significant (P<0.05)
increase in the total creatine kinase activity, which was used
as a biochemical marker of differentiation. (See Table II.)
Effects of FCS on proliferation in vitro
Growth rate Under the conditions of our experiments, FCS
deprivation resulted in a statistically significant (P<0.001)
temporary retardation of growth. (See Figure 2.) After three
days in culture, the cell density of FCS-depleted culture
flasks (7.9 x 105 +5 x 104 cells per culture flask) remained
below the cell density of the control (1.7 x 106 +2.4 x 105 cells
per culture flask). Detrimental effects of FCS-depletion on
cell viability could be excluded by the trypan blue exclusion
test. After three days in culture, BA-HAN-IC cells exhibited
a mean doubling time of 16 hours that did not differ
between FCS-depleted growth medium and standard growth
medium. The initial growth retardation by FCS-deprivation
was compensated for during the next days in culture by a
delayed plateau phase of growth when compared to the
control. Thus, after 7 days in culture the cell density per
culture flask did not significantly differ between FCS-
depleted culture flasks (3.9 x 106 +2.5 x 105 cells per culture
flask) and control flasks (4.7 x 106 +7.2 x 105 cells per culture
flask).
Plating efficiency Pretreatment with FCS-depleted growth
medium for 1 week and plating in FCS-depleted growth
medium markedly affected the plating efficiency, prohibiting
any colony formation at cell concentrations of up to 10 cells
per microwell. (See Table III.)
Effects of retinoic acid on cellular differentiation
In vitro morphology Seventy-two hours after exposure to
medium supplemented with 1Mm retinoic acid, the mono-
nuclear cells of BA-HAN-IC appeared to be more elongated
and spindle-shaped by phase contrast microscopy and scan-
ning electron microscopy (Figure le and f). In confluent
cultures the cells were closely aligned side-by-side in a more
orderly arrangement and piling up was significantly less
evident when compared to the criss-crossed growth pattern
under standard growth conditions (Figure la and b). Trans-
mission electron microscopy showed that about 30% of the
mononuclear tumour cells (Figure 3b, c and d) exhibited
irregular bundles of thick myofilaments (12-15nm in dia-
meter) and thin myofilaments (6-8nm in diameter), i.e.
features of rhabdomyogenic differentiation that had never
been observed in their mononuclear counterparts (Figure 3a)
under standard growth conditions. Substantial amounts of
monoparticulate glycogen deposits (Figure 3e) were found in
these mononuclear cells, too, and some mononuclear cells
contained networks of T-system-like tubules (Figure 3f). The
ultrastructural characteristics of myotube-like giant cells did
not differ from those of their multinuclear counterparts
under standard conditions.
Fusion assay Exposure to retinoic acid resulted in a marked
dose-dependent increase in the absolute number of myotube-
like giant cells after 96 hours in culture. The relative
frequency of myotube-like giant cells, i.e. the ratio between
the number of myotube-like giant cells and the total number
of cells per culture flask, exhibited a statistically significant
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Figure 1 Scanning electron microscopy and phase contrast microscopy of BA-HAN-IC cells grown for one week in standard
growth medium (a, b), in medium supplemented with 1% FCS (c, d), or with I pM retinoic acid (e, f): small mononuclear cells
exhibiting a criss-crossed growth pattern in standard growth medium (a) and FCS-depleted medium (c) as opposed to the more
regular arrangement in medium supplemented with retinoic acid (e). Abundant myotube-like giant cells (arrows) in FCS-depleted
medium (d) and in medium supplemented with retinoic acid (f) as opposed to sparsely distributed myotube-like giant cells (arrow)
in standard growth medium (b). a-f: bar=20,pm.
Table I Fusion assay of BA-HAN-IC tumour cells in FCS-depleted medium and in medium
supplemented with retinoic acid
number of myotube-like giant cellsa x 104 Number of myotube- Ratio-
like giant cellsa total number of cells
After
Initially 96 hours Initially After 96 hours
Control 14.7+ 1.2 75+ 7.2 0.49+0.04 0.10+0.01
5% FCS 9.3+2.1 365+216 0.31 +0.07 0.51 +0.31
1% FCS 11.0+5.6 1741+543 0.36+0.19 3.57+0.95
Control 4.8+2.2 32.8+2.2 0.16+0.07 0.04+0.00
O.lM retinoic acid 5.8+2.5 234+80 0.19+0.08 0.30+0.13
1pM retinoic acid 5.2+ 1.8 2301 +297 0.17+0.06 3.09+0.33
aIn 1/32 the growth area of a culture flask. Each value represents the mean+standard deviation of
five replicate experiments. The dose-dependent increase of the ratio between the number of myotube-
like giant cells and the total number of cells is highly significant (P<0.001; analysis of variance with
two independent factors, repeated measurements in one factor, i.e. time).
Total creatine kinase activity Exposure of BA-HAN-iC EfJects of retinoic acid on proliferation in vitro
tumour cells to growth medium supplemented with 1 gM
retinoic acid for 10 days resulted in a statistically significant Growth rate Under the conditions of our experiment, expo-
(P<0.05) increase in the total creatine kinase activity used as sure to retinoic acid resulted in a statistically significant
a biochemical marker of differentiation. (P<0.001) inhibition of proliferation. (See Figure 4.) Detri-
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Table II Creatine kinase activity of BA-HAN-IC
tumour cells after 10 days in standard growth medium
(control), FCS-depleted medium and in medium sup-
plemented with retinoic acid
Creatine kinase activity
(mU/5 x 106 cells)
Control 120+15
Medium supplemented
with 1% FCS 1290+50
Medium supplemented
with 1gM retinoic acid 7090+ 1060
Each value represents the mean+standard deviation
of three replicate samples. The difference was statisti-
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Figure 2 Growth curves of BA-HAN-IC in standard growth
medium (control) and in medium supplemented with 1% FCS.
Each value represents the mean of three replicate samples+stan-
dard deviation. The difference between the growth curves is
statistically significant (P<0.001; analysis of variance with two
independent factors). a-b: mean doubling time of 16 hours.
Table III Plating efficiency of BA-HAN-IC tumour cells
in per cent of the control after exposure to FCS-depleted




Growth medium supplemented with
1% FCS l yM retinoic acid
mental effects of retinoic acid on cell viability could be
excluded by the trypan blue exclusion test. After 3 days, BA-
HAN-IC cells exposed to retinoic acid exhibited a mean
doubling time of 17 hours as compared to a mean doubling
time of about 16 hours under standard growth conditions.
The prolongation of the mean doubling time by exposure to
retinoic acid became increasingly evident after the third day
in culture. As a result, the cell density per culture flask
during the plateau phase of growth after 7 days differed
markedly between the control (6.4 x 106+2.8 x105 cells per
culture flask) and cultures exposed to retinoic acid
(1.1 x 106±1.9x 105 cells per culture flask).
Plating efficiency Pretreatment with retinoic acid for one
week and plating in medium supplemented with retinoic acid
markedly decreased the plating efficiency when compared to
the control. (See Table III.)
Discussion
FCS is known to affect growth and cellular differentiation of
non-neoplastic myoblast cell lines derived from embryonic
skeletal muscle cells (Scarpa et al., 1975; K6nigsberg, 1977;
Yaffe & Saxel, 1977; Dollenmeier & Eppenberger, 1983;
Pinset & Whalen, 1983). Therefore, we investigated the
effects of FCS on a rhabdomyosarcoma cell line. Our results
show that FCS-deprivation results in a marked initial retar-
dation of proliferation (Figure 2) and in a simultaneous
induction of differentiation as indicated by the increase in
the number of myotube-like giant cells (Table I) and in the
creatine kinase activity (Table II). These effects may be
explained by the concept of an autocrine stimulation of
proliferation, proposed by Sporn and Todaro (1980).
According to this concept, cancer cells do not proliferate
absolutely autonomously but in response to polypeptide
growth factors, which are constitutively synthesised by the
tumour cells (De Larco & Todaro, 1978; Todaro et al., 1980;
Marquardt et al., 1983). Autocrine stimulation of tumour
cell proliferation, however, can be bypassed with exogeneous
growth factors supplemented with calf serum. Thus, fetal
calf serum has been shown to contain potent polypeptide
growth factors such as PDGF, EGF and TGF-# (Alexander,
1985; Heldin et al., 1985, 1986; Florini et al., 1986; Harris et
al., 1986; Sporn et al., 1987). Consequently, FCS-deprivation
in tissue culture media results in growth retardation, as
could also be seen in our rhabdomyosarcoma cell line.
However, the proliferation of our rhabdomyosarcoma cell
line in FCS-depleted medium (Figure 2) markedly acceler-
ated after 3 days in culture, when a minimum cell density
had been achieved, which possibly provided a sufficient
concentration of autocrine growth factors. The temporary
retardation of growth observed after FCS-deprivation was
accompanied by an increase in the proportion of terminally
differentiated myotube-like giant cells. This observation sug-
gests that the inverse linkage between proliferation and
differentiation, which is known from normal embryonic
myogenesis (Nadal-Ginard, 1978), has been preserved in our
rhabdomyosarcoma cell line.
Retinoic acid is known to affect the proliferation and
differentiation of both non-neoplastic and neoplastic cells
(Lotan, 1979; Sporn & Roberts, 1983; Chytil, 1986;
Lippmann et al., 1987a, b), sometimes even converting
tumour cells to terminally differentiated postmitotic cells
(Strickland & Mahdavi, 1978; Linder et al., 1981; Sherman
et al., 1985; Garvin et al., 1986; Paukovits et al., 1986; Sidell
et al., 1986). Our results show that retinoic acid inhibits
proliferation and simultaneously induces terminal differentia-
tion in our rhabdomyosarcoma cell line. After exposure to
retinoic acid, the proliferation of BA-HAN-IC cells was
significantly inhibited, and the tumour cells exhibited a more
orderly arrangement with less piling up in confluent cultures
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II
Figure 3 Transmission electron microscopy of BA-HAN-IC cells: mononuclear tumour cells in standard growth medium (a)
lacking rhabdomyogenic features of differentiation. Mononuclear cell after exposure to I M retinoic acid for one week (b)
exhibiting an extensive cytoplasmatic area (star) with irregular bundles of thick and thin myofilaments shown in more detail in c
and d. Monoparticulate glycogen deposits (e) and T-system-like tubules (f) in a mononuclear cell after exposure to retinoic acid. a,
b, bar=2p,m; c-f: bar=0.4,im.
(Figure le), suggesting a partial restoration of the contact
inhibition of proliferation after exposure to retinoic acid
(Lotan, 1980). The effects of retinoic acid on proliferation
were paralleled by a statistically significant increase in the
frequency of terminally differentiated post-mitotic myotube-
like giant cells (Table I) and an increase in the creatine
kinase activity used as a biochemical marker of differentia-
tion (Table II). Furthermore, about 30% of the mononuclear
tumour cells exhibited morphological features of rhabdo-
myogenic differentiation, which had never been observed in
the mononuclear tumour cells of untreated cultures (Figure
3). We did not succeed, however, in converting all the cells
of BA-HAN-IC into terminally differentiated post-mitotic
myotube-like giant cells after exposure to retinoic acid. In
our clonal cell line BA-HAN-1C, the coexistence of diverse
subpopulations is not very likely to account for this partial
refractoriness to retinoic acid as was suggested for other
tumour models (Sherman et al., 1986; Zile et al., 1987).
Therefore, BA-HAN-IC tumour cells might in some way be
epigenetically blocked from responding to retinoic acid, as
was discussed for an embryonal carcinoma cell line by
Sherman et al. (1986).
All things considered, there is an overlap in the effects of
FCS-deprivation and exposure to retinoic acid. The effects of
FCS-deprivation on the proliferation and differentiation of
our rhabdomyosarcoma cell line BA-HAN-IC suggested that
polypeptide growth factors not yet chemically defined might
be active in our cell line, too, stimulating proliferation in an
autocrine manner. On the other hand, retinoic acid was
recently shown to modulate the effects of polypeptide growth
factors and the actions of oncogenes or the proteins encoded
by these oncogenes (Jetten, 1980; Craig et al., 1984;
Amatruda et al., 1985; Thiele et al., 1985; Bentley &
Groudine, 1986). Therefore, our clonal cell line should
provide a useful system for further investigations concerning
the interrelations between polypeptide growth factors and
retinoic acid, both of which affect the proliferation and
differentiation of tumour cells.
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Figure 4 Growth curves of BA-HAN-IC in standard growth
medium with 0.02% ethanol (control) and in medium supple-
mented with 11 m retinoic acid. Each value represents the mean
of three replicate samples+standard deviation. The difference
between the growth curves is statistically significant (P<0.001;
analysis of variance with two independent factors). a: mean
doubling time of 16 hours. b: mean doubling time of 17 hours.
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